Innoviva (INVA) Dividends Paid - Common (QoQ) (2014 - 2022)
Innoviva (INVA) Dividends Paid - Common (QoQ) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 995.80 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 631.23% |
| Jun 30, 2022 | 46.72% |
| Sep 30, 2021 | 129.94% |
| Jun 30, 2021 | -5.28% |
| Mar 31, 2021 | 747.33% |
| Jun 30, 2020 | -23.14% |
| Mar 31, 2020 | 249.97% |
| Dec 31, 2019 | -200.00% |
| Sep 30, 2019 | 95,736.36% |
| Dec 31, 2018 | 54.20% |
| Sep 30, 2018 | 145.86% |
| Jun 30, 2018 | 798.89% |
| Mar 31, 2018 | -33.33% |
| Dec 31, 2017 | -7.53% |
| Sep 30, 2017 | 317.91% |
| Jun 30, 2017 | -200.00% |
| Mar 31, 2017 | 3.08% |
| Dec 31, 2016 | 25.00% |
| Sep 30, 2016 | -58.06% |
| Jun 30, 2016 | -82.75% |